BiotechTube
Home/Syna Therapeutics/Isabel Amat
IA

Isabel Amat

Board Member

Syna Therapeutics

Therapeutic Areas

HematologyOncology

Syna Therapeutics Pipeline

DrugIndicationPhase
LB-0702Hematology pathologiesPre-clinical

Leadership Team at Syna Therapeutics

DA
Dr. Andreu Soldevila
Co-founder & CEO
GR
Gabriel Roig
Chairman of the Board
View full Syna Therapeutics profile